The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events
Conclusions:
AEs were common, but not more frequent or severe among MDR-TB/HIV co-infected participants receiving concurrent antiretroviral therapy. Given the favorable treatment outcomes associated with concurrent treatment, antiretroviral therapy initiation should not be delayed in MDR-TB patients with HIV-coinfection.
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Clinical Science Source Type: research
More News: African Health | Audiometry | Brain | Eyes | Infectious Diseases | Laboratory Medicine | Multidrug Resistance | Neurology | Neuroscience | Peripheral Neuropathy | Science | South Africa Health | Study | Tuberculosis